Cargando…
Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
Pulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients’ survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ig...
Autores principales: | Nuche, Jorge, Palomino-Doza, Julián, Ynsaurriaga, Fernando Arribas, Delgado, Juan F., Ibáñez, Borja, Oliver, Eduardo, Subías, Pilar Escribano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177585/ https://www.ncbi.nlm.nih.gov/pubmed/32260370 http://dx.doi.org/10.3390/ijms21072509 |
Ejemplares similares
-
Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension
por: Nuche, Jorge, et al.
Publicado: (2020) -
Clinical course of COVID-19 in pulmonary arterial hypertension patients
por: Nuche, Jorge, et al.
Publicado: (2020) -
Curso clínico de la COVID-19 en pacientes con hipertensión arterial pulmonar
por: Nuche, Jorge, et al.
Publicado: (2020) -
Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients
por: Segura de la Cal, Teresa, et al.
Publicado: (2020) -
COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
por: Segura de la Cal, Teresa, et al.
Publicado: (2021)